ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Orchestra BioMed Holdings Inc

Orchestra BioMed Holdings Inc (OBIO)

4.92
0.12
(2.50%)
Closed December 22 3:00PM
4.92
0.02
(0.41%)
After Hours: 3:25PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
4.92
Bid
4.31
Ask
5.00
Volume
191,268
4.49 Day's Range 4.98
4.22 52 Week Range 10.44
Market Cap
Previous Close
4.80
Open
4.64
Last Trade Time
Financial Volume
US$ 896,616
VWAP
4.6877
Average Volume (3m)
53,108
Shares Outstanding
38,013,526
Dividend Yield
-
PE Ratio
-3.79
Earnings Per Share (EPS)
-1.29
Revenue
2.76M
Net Profit
-49.12M

About Orchestra BioMed Holdings Inc

Health Sciences Acquisitions Corp 2 is a blank check company. Health Sciences Acquisitions Corp 2 is a blank check company.

Sector
Surgical,med Instr,apparatus
Industry
Blank Checks
Headquarters
Grand Cayman, Cym
Founded
2023
Orchestra BioMed Holdings Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker OBIO. The last closing price for Orchestra BioMed was US$4.80. Over the last year, Orchestra BioMed shares have traded in a share price range of US$ 4.22 to US$ 10.44.

Orchestra BioMed currently has 38,013,526 shares outstanding. The market capitalization of Orchestra BioMed is US$182.46 million. Orchestra BioMed has a price to earnings ratio (PE ratio) of -3.79.

OBIO Latest News

Orchestra BioMed Announces AVIM Therapy Program Presentations at ICI Meeting

NEW HOPE, Pa., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical innovation company accelerating high-impact...

Orchestra BioMed to Participate in the Piper Sandler 36th Annual Healthcare Conference

NEW HOPE, Pa., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies...

Orchestra BioMed Reports Third Quarter 2024 Financial Results and Provides a Business Update

NEW HOPE, Pa., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical innovation company accelerating high-impact...

Precision Neuroscience Expands Executive Team as Brain–Computer Interface Industry Rapidly Advances

NEW YORK, July 23, 2024 (GLOBE NEWSWIRE) -- Precision Neuroscience Corporation (Precision), a leader in developing brain–computer interface technology to restore function and autonomy for...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.41-7.692307692315.335.384.36605044.88770351CS
4-0.58-10.54545454555.56.14.36567295.28806543CS
120.091.863354037274.836.54.36531085.48281428CS
26-2.57-34.31241655547.498.86994.36901556.72128329CS
52-5.13-51.044776119410.0510.444.22739076.75654705CS
156-6.83-58.127659574511.7523.394.22828298.2880997CS
260-6.83-58.127659574511.7523.394.22828298.2880997CS

OBIO - Frequently Asked Questions (FAQ)

What is the current Orchestra BioMed share price?
The current share price of Orchestra BioMed is US$ 4.92
How many Orchestra BioMed shares are in issue?
Orchestra BioMed has 38,013,526 shares in issue
What is the market cap of Orchestra BioMed?
The market capitalisation of Orchestra BioMed is USD 182.46M
What is the 1 year trading range for Orchestra BioMed share price?
Orchestra BioMed has traded in the range of US$ 4.22 to US$ 10.44 during the past year
What is the PE ratio of Orchestra BioMed?
The price to earnings ratio of Orchestra BioMed is -3.79
What is the cash to sales ratio of Orchestra BioMed?
The cash to sales ratio of Orchestra BioMed is 67.49
What is the reporting currency for Orchestra BioMed?
Orchestra BioMed reports financial results in USD
What is the latest annual turnover for Orchestra BioMed?
The latest annual turnover of Orchestra BioMed is USD 2.76M
What is the latest annual profit for Orchestra BioMed?
The latest annual profit of Orchestra BioMed is USD -49.12M
What is the registered address of Orchestra BioMed?
The registered address for Orchestra BioMed is PO BOX 309, UGLAND HOUSE, GRAND CAYMAN, KY1 1104
Which industry sector does Orchestra BioMed operate in?
Orchestra BioMed operates in the BLANK CHECKS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MYSZMy Size Inc
US$ 4.2001
(211.12%)
120.01M
NVNINVNI Group Ltd
US$ 8.26
(209.36%)
76.64M
TPICTPI Composites Inc
US$ 2.45
(100.82%)
33.95M
ICGIntchains Group Ltd
US$ 8.77
(88.60%)
527.61k
HSDTHelius Medical Technologies Inc
US$ 0.884851
(84.34%)
120.4M
CYNCYNGN Inc
US$ 0.4603
(-71.41%)
27.91M
MTEMMolecular Templates Inc
US$ 0.1502
(-57.09%)
8.75M
PRFXPainReform Ltd
US$ 5.15
(-53.85%)
2.94M
GALTGalectin Therapeutics Inc
US$ 1.03
(-48.50%)
9.27M
BCABBioAtla Inc
US$ 0.6923
(-41.82%)
6.25M
EDBLEdible Garden AG Inc
US$ 0.24
(65.06%)
354.32M
APTOAptose Biosciences Inc
US$ 0.28
(64.51%)
305.1M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.606999
(6.49%)
292.16M
NVDANVIDIA Corporation
US$ 134.70
(3.08%)
287.21M
PLTRPalantir Technologies Inc
US$ 80.55
(8.54%)
277.63M

Your Recent History

Delayed Upgrade Clock